Smita Bhatia, M.D., professor in the Division of Pediatric Hematology/Oncology, has been invited to serve as a member of the Clinical Trials and Translational Research Advisory Committee (CTAC) of the National Cancer Institute (NCI).
The CTAC advises and makes recommendations on the conduct, oversight, and implementation of clinical trials and translational research programs across the NCI. Dr. Bhatia will serve on the committee through July 31, 2025.
Dr. Bhatia will bring her expertise in pediatric oncology, cancer outcomes and survivorship to the committee and provide important perspectives to discussions related to NCI’s clinical trials and translational research programs.
Congratulations Dr. Bhatia!